Mergers and Acquisitions (M&A): Esperion Therapeutics (NASDAQ: ESPR) to Acquire Corstasis Therapeutics
Ann Arbor, MI – Esperion Therapeutics has announced the acquisition of Corstasis Therapeutics (https://corstasis.com/). According to the company announcement, Esperion Therapeutics, Inc. is a commercial-stage biopharmaceutical company dedicated to developing and delivering innovative cardiometabolic and…